Royalty Pharma Plc Cl A (RPRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
33.70 +0.20 (+0.60%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.85 +0.15 (+0.45%) 19:29 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,330,813 | 1,700,088 | 230,064 | 1,241,201 | 1,701,954 |
| Depreciation Amortization | 19,562 | 20,499 | 27,026 | 43,158 | 34,773 |
| Accounts receivable | -4,551 | -1,521 | -4,744 | -29,143 | -400 |
| Other Working Capital | 887,371 | 1,009,038 | 414,802 | 234,449 | 202,962 |
| Other Operating Activity | 535,791 | 259,698 | 1,476,832 | 527,871 | 95,340 |
| Operating Cash Flow | $2,768,986 | $2,987,802 | $2,143,980 | $2,017,536 | $2,034,629 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,505,701 | -2,115,522 | -1,741,640 | -2,191,502 | N/A |
| PPE Investments | -18,000 | N/A | -21,215 | N/A | -2,182,246 |
| Purchase Of Investment | -298,455 | -24,942 | -812,109 | -1,455,609 | -1,795,438 |
| Sale Of Investment | 142,002 | 69,713 | 1,545,543 | 1,776,831 | 1,203,280 |
| Other Investing Activity | 2,039 | -2,038 | 0 | 0 | 15,084 |
| Investing Cash Flow | $-2,678,115 | $-2,072,789 | $-1,029,421 | $-1,870,280 | $-2,759,320 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 350,000 | N/A | N/A | N/A |
| Debt Issued | 1,471,235 | N/A | N/A | 1,272,533 | 11,891,030 |
| Debt Repayment | N/A | -1,000,000 | N/A | N/A | -11,210,400 |
| Common Stock Issued | 5,107 | 7,476 | 7,192 | 44,213 | 1,976,183 |
| Common Stock Repurchased | -229,651 | -304,759 | N/A | N/A | N/A |
| Dividend Paid | -863,904 | -854,848 | -950,701 | -918,588 | -1,122,930 |
| Other Financing Activity | -21,642 | -346,623 | -1,347 | -13,046 | -46,711 |
| Financing Cash Flow | $361,145 | $-2,148,754 | $-944,856 | $385,112 | $1,487,172 |
| Beginning Cash Position | 477,010 | 1,710,751 | 1,541,048 | 1,008,680 | 246,199 |
| End Cash Position | 929,026 | 477,010 | 1,710,751 | 1,541,048 | 1,008,680 |
| Net Cash Flow | $452,016 | $-1,233,741 | $169,703 | $532,368 | $762,481 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,768,986 | 2,987,802 | 2,143,980 | 2,017,536 | 2,034,629 |
| Capital Expenditure | -18,000 | N/A | -21,215 | N/A | -2,182,246 |
| Free Cash Flow | 2,750,986 | 2,987,802 | 2,122,765 | 2,017,536 | -147,617 |